Avidity Biosciences, Inc. (RNA)
NASDAQ: RNA · IEX Real-Time Price · USD
25.52
+0.85 (3.45%)
At close: Mar 28, 2024, 4:00 PM
25.40
-0.12 (-0.47%)
After-hours: Mar 28, 2024, 7:36 PM EDT

Avidity Biosciences Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Year 202320222021202020192018
Cash & Equivalents
185.38340.65320.7321.7194.583.09
Short-Term Investments
410.27270.3385.16.6800
Cash & Cash Equivalents
595.65610.98405.79328.3994.583.09
Cash Growth
-2.51%50.56%23.57%247.22%2960.78%-
Other Current Assets
15.6611.965.353.291.10.15
Total Current Assets
611.31622.94411.14331.6895.683.24
Property, Plant & Equipment
16.6515.0115.591.920.630.7
Other Long-Term Assets
0.60.850.850.30.60.04
Total Long-Term Assets
17.2515.8616.442.221.230.74
Total Assets
628.56638.8427.58333.996.913.98
Accounts Payable
34.3432.5714.097.752.311.57
Deferred Revenue
69.266.2811.415.8418.940
Current Debt
3.643.111.7702.772.75
Other Current Liabilities
-26.569.962.41-9-13.790.31
Total Current Liabilities
80.6851.9129.6614.5910.244.62
Long-Term Debt
6.217.589.960.942.167.58
Other Long-Term Liabilities
40.91.246.5312.1515.1532.92
Total Long-Term Liabilities
47.118.8216.4913.0917.3140.5
Total Liabilities
127.7960.7346.1527.6827.5445.11
Total Debt
9.8510.6911.730.944.9410.32
Debt Growth
-7.81%-8.88%1150.43%-81.00%-52.18%-
Retained Earnings
-570.76-358.54-184.55-66.54-22.19-41.56
Comprehensive Income
0.13-2.7-0.19-0.0100
Shareholders' Equity
500.76578.08381.43306.22-65.36-41.13
Net Cash / Debt
585.79600.29394.07327.4589.64-7.23
Net Cash / Debt Growth
-2.41%52.33%20.34%265.29%--
Net Cash Per Share
8.0211.519.5115.1233.04-2.92
Working Capital
530.63571.03381.48317.0985.44-1.37
Book Value Per Share
6.8611.089.2114.14-24.09-16.60
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).